Nonpegylated liposomal doxorubicin (Myocet™) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): Results from the phase II EUR018 trial

1. Luminari, S.
2. Montanini, A.
3. Caballero, D.
4. Bologna, S.
5. Notter, M.
6. Dyer, M.J.S.
7. Chiappella, A.
8. Briones, J.
9. Petrini, M.
10. Barbato, A.
11. Kayitalire, L.
12. Federico, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDP544 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•